HCPS

Migraine Digital Marketing Analysis Report 2022: Biohaven's Nurtec.com Achieved the Highest traffic Across Branded Patient Sites in the US from July 2021 to June 2022

Retrieved on: 
Thursday, December 1, 2022
HCP, Digital, AbbVie, HCPS, Allergan, Amgen, Social media, Patient, Eli Lilly and Company, Comparison, Galcanezumab, DDA, SEO, Lundbeck, Pharmaceutical industry, Generic drug, Online shopping, Teva, Migraine

Biohaven's Nurtec.com achieved the highest traffic across branded patient sites in the US from July 2021 to June 2022, with about 14,500,000 visits, followed by Eli Lilly's Emgality.com and Allergan's Botoxchronicmigraine.com.

Key Points: 
  • Biohaven's Nurtec.com achieved the highest traffic across branded patient sites in the US from July 2021 to June 2022, with about 14,500,000 visits, followed by Eli Lilly's Emgality.com and Allergan's Botoxchronicmigraine.com.
  • The highest proportion of traffic to these sites originated from direct sources, followed by referrals and organic traffic.
  • For patient branded sites, Lundbeck spent the most on digital display advertising (DDA) for Vyepti.com at $4.6 million, followed by Allergan's Botoxchronicmigraine.com at $4.3 million.
  • Understand the digital marketing competitive landscape in migraine, with a view of leading patient and HCP branded assets across different regions.

HAVAS HEALTH & YOU EXPANDS CONTENT EXPERTISE THROUGH PARTNERSHIP WITH EVERMED

Retrieved on: 
Thursday, December 1, 2022
Lynx, COVID-19, Growth, AI, Multimedia, HCPS, Partnership, Patient, Content Assembly Mechanism, Medicine, HH, Health, Human, News

To help address the need for more content-focused solutions to reach HCPs more effectively, Havas Health & You (HH&Y) today announced a global partnership with Evermed, a technology company whose modular content hubs power personalized video content delivery for life science companies and HCPs.

Key Points: 
  • To help address the need for more content-focused solutions to reach HCPs more effectively, Havas Health & You (HH&Y) today announced a global partnership with Evermed, a technology company whose modular content hubs power personalized video content delivery for life science companies and HCPs.
  • In partnership with HH&Y's deep knowledge of content and their global reach, the two will work together to provide tailored content strategies to drive growth for both companies.
  • HH&Y's partnership with Evermed follows a sequence of events to foster the network's content capabilities that kicked off with the formation of its Content Assembly division.
  • Havas Health & You unites Havas Life, Health4Brands (H4B), Lynx, Red Havas and Havas Health Plus, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group.

HAVAS HEALTH & YOU EXPANDS CONTENT EXPERTISE THROUGH PARTNERSHIP WITH EVERMED

Retrieved on: 
Thursday, December 1, 2022
Lynx, COVID-19, Growth, AI, HCPS, Partnership, Patient, Content Assembly Mechanism, Medicine, HH, Health, Human, Pharmaceutical industry

To help address the need for more content-focused solutions to reach HCPs more effectively, Havas Health & You (HH&Y) today announced a global partnership with Evermed, a technology company whose modular content hubs power personalized video content delivery for life science companies and HCPs.

Key Points: 
  • To help address the need for more content-focused solutions to reach HCPs more effectively, Havas Health & You (HH&Y) today announced a global partnership with Evermed, a technology company whose modular content hubs power personalized video content delivery for life science companies and HCPs.
  • In partnership with HH&Y's deep knowledge of content and their global reach, the two will work together to provide tailored content strategies to drive growth for both companies.
  • HH&Y's partnership with Evermed follows a sequence of events to foster the network's content capabilities that kicked off with the formation of its Content Assembly division.
  • Havas Health & You unites Havas Life, Health4Brands (H4B), Lynx, Red Havas and Havas Health Plus, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group.

Syneos Health Releases 2023 Health Trends

Retrieved on: 
Thursday, December 1, 2022
Population health, Growth, Mental health, Culture, Housing, Environment, Institute for Healthcare Advancement, Occupational burnout, Organization, Work, AI, Machine learning, HCPS, Safety, Life, Patient, Transport, Government, Medical Affairs Bureau, Medicine, Thought, Technological evolution, Health, Artificial intelligence, Syneos Health, Clinical trial, Vaccine, Medical device, Pharmaceutical industry, Management, Healthcare

MORRISVILLE, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2023 Health Trends: Personally, Purposely Building What's Next.

Key Points: 
  • MORRISVILLE, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2023 Health Trends: Personally, Purposely Building What's Next.
  • According to Syneos Health 2023 Health Trends, the 12 trends set to catalyze the year ahead align around Technology Evolution, Human Engagement and Healthcare Advancement.
  • Subscribe to the Syneos Health podcast for further coverage of the 2023 Health Trends and implications for biopharmaceutical companies in the new year.
  • Editors Note: More than 100 Subject Matter Experts across Syneos Health contributed content to 2023 Health Trends.

RxDefine is now Ostro

Retrieved on: 
Wednesday, November 30, 2022
Marketing, Infection, Organization, Multimedia, HCPS, Cardiovascular disease, Neurology, Patient, Founders Fund, MD, Health, Pharmaceutical industry, Ostro

MIAMI, Nov. 30, 2022 /PRNewswire/ -- RxDefine, a leading healthcare engagement platform for consumers and HCPs, today announced that the company has launched a new visual identity and officially changed its name to Ostro. Ostro's name change comes on the heels of closing an additional $45 million in funding from Founders Fund, Byers Capital, Caffeinated Capital, Greycroft, Bling Capital, Trust Ventures, and RRE Ventures, bringing Ostro's total funding to over $55M.

Key Points: 
  • "This name change and new identity signals an important new chapter for Ostro," said Chase Feiger, MD, CEO of Ostro.
  • In conjunction with changing the company name, Ostro is also renaming its product suite, which is now composed of Ostro Navigate, Ostro Attribute, and Ostro Consult.
  • "This name change and new identity signals an important new chapter for Ostro," said Chase Feiger, MD, CEO of Ostro.
  • The Ostro platform is composed of Ostro Navigate, a 1:1 experience that offers consumers and HCPs a personalized journey to help address their needs; Ostro Attribute, an analytics product that connects brand marketing campaigns to clinical outcomes to increase the impact of commercial spend; and Ostro Consult, a telehealth experience that supports the engagement journey by connecting patients to an experienced and qualified clinician.

Verana Health to Enable Cloud-based Access to its Curated, De-identified Real-World Data Through AWS Data Exchange

Retrieved on: 
Wednesday, November 30, 2022
SAN, HCP, EHR, Health, American Academy of Neurology, HCPS, Amazon Web Services, Neurology, American Urological Association, Patient, Data management, Amazon, Medicine, AWS, Drug development, RWD, American Academy of Ophthalmology, Research, Quality of life, Intelligence, American Academy, Medical imaging, Pharmaceutical industry, Ophthalmology

Offering de-identified electronic health record (EHR)-derived data from ophthalmology, neurology, and urology clinical data registries through AWS Data Exchange allows Verana Health to provide its life sciences customers with an easy, convenient, and secure method of accessing high-quality, de-identified clinical RWD for research use.

Key Points: 
  • Offering de-identified electronic health record (EHR)-derived data from ophthalmology, neurology, and urology clinical data registries through AWS Data Exchange allows Verana Health to provide its life sciences customers with an easy, convenient, and secure method of accessing high-quality, de-identified clinical RWD for research use.
  • Customers will be able to access the AWS Data Exchange directly from their Verana Health dashboard.
  • Verana Health transforms structured and unstructured healthcare data into de-identified, curated data modules called Qdata, a clinician-led and artificial intelligence (AI)-enhanced process enabled by its VeraQ population health data engine.
  • Using its clinician-informed and artificial intelligence-enhanced VeraQpopulation health data engine, Verana Health transforms structured and unstructured healthcare data into curated, disease-specific data modules, Qdata.

Survey Reveals Caregivers Identify Emotional Support for Themselves As Top Information, Resource Need

Retrieved on: 
Tuesday, November 29, 2022
Mental health, Atrium Health Union, Multimedia, HCPS, Health, Caregiver, Learning, Patient, Residential care

PHILADELPHIA , Nov. 29, 2022 /PRNewswire/ -- A new survey from Health Union, the leader in social health, shows caregivers and care partners are most in need of information and resources to better support their emotional health, in addition to resources concerning decision-making and patient care. The findings from the Caregiving In America survey, which featured current and former caregivers of people living with chronic and complex health conditions, can provide the healthcare industry with a better understanding of the types of content and resources caregivers identify as important, and how to deliver those resources.

Key Points: 
  • An analysis of the 170 Caregiving In America survey respondents who are currently caregivers reveals they are interested in more information or resources about how to improve their own emotional and mental health and well-being.
  • Current caregivers identified emotional support for themselves (59%) as the top information or resource they need more of, followed by emotional support for the patient (48%), how to create time to rest or rejuvenate (44%) and financial support or assistance (32%).
  • One major stressor is the need to provide emotional support to the patient.
  • In addition to 92% of current caregivers saying they provide their patient with emotional support, this was identified by respondents as the most difficult task they provide.

Veeva Pulse Shows Europe HCP Access Averages 52% with Largest Growth in Content-Driven Digital Engagement Worldwide

Retrieved on: 
Tuesday, November 29, 2022
Growth, Professional corporation, HCP, United Kingdom, HCPS, Veeva Systems, NYSE, Video game, Pharmaceutical industry

BARCELONA, Spain, Nov. 29, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released the first view of healthcare professional (HCP) access across key European markets from the Veeva Pulse Field Trends Report, the largest global industry benchmark of its kind on HCP engagement. Data shows European HCP access now averages 52% across countries, driven by the increasing use of video meetings and content to complement in-person visits.

Key Points: 
  • Data shows European HCP access now averages 52% across countries, driven by the increasing use of video meetings and content to complement in-person visits.
  • Latest Veeva Pulse data show combination of video and in-person meetings maximize field access:
    Post-pandemic HCP access is higher than expected: Overall HCP accessibility is now at 52%.
  • Content use rises with growth of video meetings: Europe saw the most dramatic increase in content utilization globally.
  • Analyzing over 600 million HCP interactions and activities annually from more than 80% of commercial biopharma field teams worldwide, the Veeva Pulse Field Trends Report is the largest industry benchmark of its kind on HCP engagement.

PHYSICIAN'S WEEKLY PARTNERS WITH THE NATIONAL ALLIANCE FOR HISPANIC HEALTH TO STRENGTHEN ITS COMMITMENT TO DIVERSITY AND INCLUSION IN HEALTHCARE

Retrieved on: 
Monday, November 28, 2022
Culture, Weekly, Editorial, Science, Communication, Multimedia, National Alliance, HCPS, CME, Knowledge, Social media, Physician, National Alliance for Hispanic Health, Patient, Education, Health equity, Health, Medicine

"Diversity and inclusion enhance our ability to understand and best serve people across all cultures and backgrounds," said Greg Jackson, CEO, Physician's Weekly.

Key Points: 
  • "Diversity and inclusion enhance our ability to understand and best serve people across all cultures and backgrounds," said Greg Jackson, CEO, Physician's Weekly.
  • Working with Physician's Weekly is a meaningful way to provide cutting edge information when and where healthcare decisions are made," said Dr. Jane Delgado, President, and CEO of the National Alliance for Hispanic Health.
  • A must-listen for healthcare professionals, please follow and listen to The Physician's Weekly podcast hosted by Dr. Rachel Giles.
  • The National Alliance for Hispanic Health is the premier science-based and community-driven organization that focuses on the best health for all.

Optimizing Patient Care & Clinical Research: How HCPs can Leverage Data Insights & Analytics, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, November 28, 2022
HCPS, Health, HCP, Clinical trial, Cros, Food, Pharmaceutical industry, Medicine

TORONTO, Nov. 28, 2022 /PRNewswire-PRWeb/ -- For many years, data vendors have focused exclusively on the enablement of pharma and CROs to drive more impactful, efficient clinical research. However, the need to enable healthcare professionals (HCPs) with data to direct better patient care through clinical trial awareness and accessibility hasn't been considered.

Key Points: 
  • In this free webinar, learn about data-enablement of healthcare professionals (HCPs) for better patient care and engagement in clinical trials.
  • However, the need to enable healthcare professionals (HCPs) with data to direct better patient care through clinical trial awareness and accessibility hasn't been considered.
  • Register for this webinar to learn how HCPs can leverage data insights and analytics to optimize patient care and clinical research.
  • For more information, or to register for this event, visit Optimizing Patient Care & Clinical Research: How HCPs can Leverage Data Insights & Analytics .